High Cholesterol and Heart Disease -- SPIRE Program

  • STATUS
    Not Recruiting
  • sponsor
    Pfizer
Updated on 23 November 2020

Summary

High Cholesterol and Heart Disease -- SPIRE Program

Description

WHAT IS THE SPIRE PROGRAM?

The SPIRE program is a series of clinical studies that is investigating a study drug in people who have high cholesterol. This study drug is being evaluated to understand its effects on bad cholesterol (LDL-C) and cardiovascular events such as heart attack or stroke.

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-1)

ClinicalTrials.gov identifier: NCT01975376

http://spirestudies.com/

 

ClinicalTrials.gov identifier: NCT01975376

http://spirestudies.com/

Details
Condition Coronary heart disease
Clinical Study IdentifierTX144222
SponsorPfizer
Last Modified on23 November 2020

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note